Tabagismo: diretrizes
DOI:
https://doi.org/10.25118/2763-9037.2011.v1.975Palavras-chave:
tabagismo, vício de fumarResumo
A diretoria da Associação Médica Brasileira (AMB) autoriza a publicação das Diretrizes de autoria da Associação Brasileira de Psicologia na revista Debates em Psiquiatria.
Downloads
Métricas
Referências
Alves, MJO. Eletroconvulsoterapia. Cap 12, Bipolar — 1. World Health Organization. WH 1. O Report on the global tobacco epidemic 2008: the MPower Package. Geneve: WHO, 2008.
Viegas CAA, editor. Tabagismo: do diagnóstico à saúde pública. São Paulo: Atheneu, 2007.
World Health Organization. International statistical of diseases and related health problem. Geneve: WHO, 1992.
World Health Organization. Policy recommendations for smoking cessation and treatment of tobacco dependence. Geneve: WHO, 2003.
Cinciripini PM, Hecht SS, Henningh eld JE, Manley MW, Kramer BS. Tobacco addiction: implications for treatment and cancer prevention. ) National CancerInst 1997;89:1852-67. DOI: https://doi.org/10.1093/jnci/89.24.1852
Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am) Prev Med 2008;35:158-76. DOI: https://doi.org/10.1016/j.amepre.2008.04.009
2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008;53:1217-22.
Gorin SS, Heck JE. Meta-analysis of Tobacco Counseling by Health Care Providers. Câncer Epidemiol Biomakers Prev 2004;13:2012-22. DOI: https://doi.org/10.1158/1055-9965.2012.13.12
DiClemente CC, Prochaska JO, Gilberini M. Seltef cacy and the stages of self-change in smoking. Cognit Th er Res 1985;9:181-200. DOI: https://doi.org/10.1007/BF01204849
Fagerstrôm KO, Schneider NG. Measuring nicotine depedence: a review of the Fagerstrom Tolerance Questionnaire. ) Behav Med 1989;12:159-82. DOI: https://doi.org/10.1007/BF00846549
Marques ACPR, Ribeiro M, Laranjeira R, et al. Abuso e dependência: nicotina. In: Jatene F, et al, coordenadores. Diretrizes. São Paulo: Associação Médica Brasileira; Brasília, DF: Conselho Federal de Medicina, 2003. v. 2, p. 97110.
Gilbert DG, Crauthers DM, Mooney DK, McClernon EF), Jensen RA. Eff ects of monetary contingencies on smoking relapse: infl uences of trait depression, personality and habitual nicotine intake. Exp. Clin Psychopharmacol 1999:;7:174-81. DOI: https://doi.org/10.1037//1064-1297.7.2.174
Stead L, Pereira R, Lancaster T. Telephone counseling for smoking cessation. Cochrane Database Syst Rev 2006:(3):CD 002850. DOI: https://doi.org/10.1002/14651858.CD002850.pub2
Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004:(4):CD000165. DOI: https://doi.org/10.1002/14651858.CD000165.pub2
Rice W Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev 2004;(1):CD 001188. DOI: https://doi.org/10.1002/14651858.CD001188.pub2
Instituto Nacional de Câncer. Consenso sobre abordagem e tratamento do fumante. Rio de Janeiro: Inca, 2001.
KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Resp ) 2007;29:390-417. DOI: https://doi.org/10.1183/09031936.00060806
Lancaster T, Stead LF. Individual behavioural couseling for smoking cessation. Cochrane Database Syst Rev 2008:(4):CD0011202.
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev,2008;(4):CD001007. DOI: https://doi.org/10.1002/14651858.CD000165.pub3
Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. effi cacy of varenicline, an alfa-4beta? nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63. DOI: https://doi.org/10.1001/jama.296.1.56
Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;(3):CD000146. DOI: https://doi.org/10.1002/14651858.CD000146.pub2
Hurt RD, Sachs DP, Glover ED, Off ord KP Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-202. DOI: https://doi.org/10.1056/NEJM199710233371703
Jorenby DE, Leischow SJ, Nides MA, Rennard Sl, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl) Med 1999;340:685-91. DOI: https://doi.org/10.1056/NEJM199903043400903
Gonzales D, Rennard Sl, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alfa4beta? nicotinic acetylcholine receptor partial agonist, vs sustainedrelease bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55. DOI: https://doi.org/10.1001/jama.296.1.47
TonstadS, Tonnesen P, Hajek P Williams KE, Billing CB, Reeves KR, et al. Eff ect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006;296:64-71. DOI: https://doi.org/10.1001/jama.296.1.64
Hughes JR, Stead LF, Lancaster T. Nortriptyline for smoking cessation: a review. Nicotine Tob Res 2005;7:491-9. DOI: https://doi.org/10.1080/14622200500185298
Gourlay SG, Stead LF, Benowitz NT. Clonidine for smoking cessation. Cochrane Database Syst Rev, 2004;(3):CD000058. DOI: https://doi.org/10.1002/14651858.CD000058.pub2
Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation interventionstrategies for adults and adults in special populations. Annals of Internal Medicine 2006;145:845-56. DOI: https://doi.org/10.7326/0003-4819-145-11-200612050-00142
.29 Reichert ), de Araújo AJ, Gonçalves CM, Godoy |, Chatkin JM, Sales MP, et al. Diretrizes para Cessação do Tabagismo - 2008. ) Bras Pneumol! 2008;34:845-80. DOI: https://doi.org/10.1590/S1806-37132008001000014
Blondal T, Gudmundsson LJ, Olafsdottir |, Gustavsson G, Westin A. icotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BM) 1999;318:285-8. DOI: https://doi.org/10.1136/bmj.318.7179.285
Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo controlled trial. Arch Intern Med 2000;160:3128-34. DOI: https://doi.org/10.1001/archinte.160.20.3128
R, Croghan GA, Sloan JA, Novotny P), et al. Randomized comparison ofa nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc 2007;82:186-95. DOI: https://doi.org/10.4065/82.2.186
Hughes JR, Wadland WC, Fenwick JW, Lewis ), Bickel WK. Eff ect of cost on the selfadministration and efficacy of nicotine gum: a preliminary study. Prev Med 1991;20:486-96. DOI: https://doi.org/10.1016/0091-7435(91)90046-7
Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996;109:438-45. DOI: https://doi.org/10.1378/chest.109.2.438
Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin DP, Bjornson-Benson WM, et al. Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. ) Consult Clin Psychol 1995;63:60-9. DOI: https://doi.org/10.1037/0022-006X.63.1.60
Covey LS, Glassman AH, Jiang H, Fried ), Masmela) , LoDuca C, et al. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction 2007/102:1292-302. DOI: https://doi.org/10.1111/j.1360-0443.2007.01887.x
Killen JD, Fortmann SP Murphy GM Jr, Hayward C, Arredondo C, Cromp D, et al. Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol 2006;74:286-94. DOI: https://doi.org/10.1037/0022-006X.74.2.286
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Eff ects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of declineo FEV1. Th e LungHealth Study. JAMA 1994;272:1497-505. DOI: https://doi.org/10.1001/jama.1994.03520190043033
Zhus, MelcerT , Sun), Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a populationbased analysis. Am J Prev Med 2000/18:305-11. DOI: https://doi.org/10.1016/S0749-3797(00)00124-0
Munafó M, Bradburn M, Bowes L, David S. Are there sex diff erences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res 2004;6:769-76. DOI: https://doi.org/10.1080/14622200410001696556
Perkins KA, Scott MA. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res 2008;10:1245-50. DOI: https://doi.org/10.1080/14622200802097506
Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007/131:446-52. DOI: https://doi.org/10.1378/chest.06-1587
Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994/154:989-95. DOI: https://doi.org/10.1001/archinte.154.9.989
Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology.J Intern Med 2002;252:130-9 DOI: https://doi.org/10.1046/j.1365-2796.2002.01014.x
Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and eff ectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005;95:976-8. Benowitz NL, Gourlay SG. Cardiovascular DOI: https://doi.org/10.1016/j.amjcard.2004.12.039
toxicity of nicotine: implications for nicotine replacement therapy.J Am Coll Cardiol 1997;29:1422-31. DOI: https://doi.org/10.1016/S0735-1097(97)00079-X
Frishman WH, Ky T, Ismail A. Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapies. Heart Dis 2001;3:365-77. DOI: https://doi.org/10.1097/00132580-200111000-00005
McRobbie H, Hajek P Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 2001;96:1547-51. DOI: https://doi.org/10.1046/j.1360-0443.2001.961115472.x
Hanson K, Allen S, Jensen S, Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res 2003;5:515-26. DOI: https://doi.org/10.1080/14622200307243
Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman S), et al. Safety and effi cacy of the nicotine patch and gum for the treatment ofadolescent tobacco addiction. Pediatrics 2005;115:8407-14. DOI: https://doi.org/10.1542/peds.2004-1894
Niederhofer H, Huber M. Bupropion may support psychosocial treatment of nicotinedependent adolescents: preliminary results. Pharmacotherapy 2004; 24:1524-8. DOI: https://doi.org/10.1592/phco.24.16.1524.50953
Curry S), Emery S, Sporer AK, Mermelstein R, Flay BR, Berbaum M, et al. A national survey of tobacco cessation programs for youths. Am J Public Health 2007;97171-7 DOI: https://doi.org/10.2105/AJPH.2005.065268
ACOG Committee on Health Care for Underdeserved Women; ACOG Committee on Obstetric Practice. ACOG committee opinion. Number 316, October 2005. Smoking cessation during pregnancy. Obstet Gynecol 2005;106:883-8. DOI: https://doi.org/10.1097/00006250-200510000-00052
Rosemberg J. Nicotina: droga universal. Rio de Janeiro: Instituto Nacional de Câncer, 2004 acesso em 22 abr. 2009. Disponível em: http://www.inca.gov.br/tabagismo/publicacoes/nicotina.pdf.
The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.
Kapur B, Hackman R, Selby P Klein ), Koren G. Randomized, double-blind, placebo controlled trial of nicotine replacement therapy in pregnancy. Curr Th er Res Clin Exp 2001;62:274-8. DOI: https://doi.org/10.1016/S0011-393X(01)80011-4
Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000;96:967-71. DOI: https://doi.org/10.1097/00006250-200012000-00019
Pollak KI Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 2007;33:297-305. DOI: https://doi.org/10.1016/j.amepre.2007.05.006
Hall SM, Tsoh JY, Prochaska )), Eisendrath S, Rossi JS, Redding CA, Rosen AB, Meisner M, Humfl eet GL, Gorecki JA. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am ) Public Health 2006;96:1808-14. DOI: https://doi.org/10.2105/AJPH.2005.080382
Prochaska JJ, Hall SM, Tsoh JY, Eisendrath 5, Rossi Js, Redding CA, et al. Treating tobacco dependence in clinically depressed smokers: eff ect of smoking cessationon mental health functioning. Am Public Health 2008;98:446-8. Hitsman B, Borrelli B, McChargue DE, Spring B, DOI: https://doi.org/10.2105/AJPH.2006.101147
Niaura R. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol 2003;/1:657-63. DOI: https://doi.org/10.1037/0022-006X.71.4.657
el-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002;53:1166-7063. DOI: https://doi.org/10.1176/appi.ps.53.9.1166
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004;72:1144-56. DOI: https://doi.org/10.1037/0022-006X.72.6.1144
Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, et al. Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol 2002;70:356-61. DOI: https://doi.org/10.1037//0022-006X.70.2.356
Rigotti N, Munafo M, Stead L. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2007:(3):CD 001837. DOI: https://doi.org/10.1002/14651858.CD001837.pub2
Molyneux A, Lewis 5, Leivers U, Anderton A, Antoniak M, Brackenridge A, et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counseling, brief counseling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003;58:484-8. DOI: https://doi.org/10.1136/thorax.58.6.484
Pinto MFT. Custos de doenças tabaco-relacionadas. Uma análise sob a perspectiva da economia e da epidemiologia. Rio de Janeiro. Tese [Doutorado] - Fundação Oswaldo Cruz; 2007.
Ministério da Saúde. Demonstrativo do custo dos medicamentos do programa nacional de controle do tabagismo em 2006. Brasília, DF: O Ministério, 2006.
Araújo AJ. Custo-efetividade de intervenções de controle do tabaco no Brasil. Rio de Janeiro. Tese [Doutorado em Engenharia de Produção] - Coordenação de Programas de Pós Graduação (COPPE) da Universidade Federal do Rio de Janeiro; 2008. p 182 acesso em 22 abr. 2009. Disponível em: http://www.4shared.com/file/94307632/6017b907/tesedoutoradoalbertocoppe2008.htm!l
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2011 Associação Médica Brasileira (ABM)
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria permite que o (s) autor (es) mantenha(m) seus direitos autorais sem restrições. Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0) - Debates em Psiquiatria é regida pela licença CC-BY-NC
